David Katz

|RSS

David Katz is the president and chief investment officer of Matrix Asset Advisors, which he co-founded in 1986. Prior to co-founding Matrix, he worked at Management Asset Corp. in the research and portfolio management areas. At Matrix, Katz chairs the Investment Policy Committee.Expand

Katz is a CFA charterholder who appears frequently as a guest on CNBC, Bloomberg Television and Radio and WCBS-AM in New York. He graduated summa cum laude from Union College with a Bachelor of Arts degree in economics. He received a Master of Business Administration degree, with a concentration in finance, from New York University Graduate School of Business in 1987, graduating with distinction. His numerous works on value investing earned him various awards and distinctions at the undergraduate and graduate levels.Collapse

RMPIA
By

David Katz

 | Jan 27, 2017 | 8:00 AM EST
Value stocks will extend their outperformance over growth stocks that began last year.
By

David Katz

 | Jan 25, 2017 | 8:00 AM EST
Management sees benefits of digital technologies for further growth.
By

David Katz

 | Jan 20, 2017 | 8:00 AM EST
Strong capital and cost controls also helped the investment banks' fourth-quarter results.
By

David Katz

 | Jan 18, 2017 | 9:00 AM EST
Wells Fargo, JPMorgan Chase and Bank of America booked solid net interest margins in 4Q.
By

David Katz

 | Jan 17, 2017 | 9:50 AM EST
This morning, Morgan Stanley reported solid results for Q4, ahead of estimates for both revenue and earnings. The company reported earnings of $0.81...
By

David Katz

 | Jan 13, 2017 | 9:00 AM EST
The company's margins and cash flows are unbelievably attractive.
By

David Katz

 | Jan 11, 2017 | 3:26 PM EST
While it's going to be a long year with headline risk (political and otherwise) for the drug companies, we do think they represent one of the more...
By

David Katz

 | Jan 11, 2017 | 8:00 AM EST
This pharma company is still making lots of money and its stock is too cheap to pass up.
By

David Katz

 | Jan 10, 2017 | 2:16 PM EST
Investors were not expecting a lot from Zimmer Biomet's (ZBH) CEO at JP Morgan Healthcare investor conference today. Investors were still reeling...
By

David Katz

 | Jan 10, 2017 | 1:36 PM EST
This morning, Larry Merlo, CEO of CVS Health, gave a presentation at the J.P. Morgan Health Care conference and reiterated the company's value...
Vacation company Norwegian Cruise Line Holdings (NCLH) posted improved results in its late...
Nice move in GPS today. The stock is up 2.7% late in the session and is holding above last...
I have read her book, 'Dare to Serve' and have seen her interviewed multiple times by Jim ...

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.